Short-term safety of mTOR inhibitors in infants and very young children with tuberous sclerosis complex (TSC): Multicentre clinical experience
Darcy A. Krueger(Cincinnati Children's Hospital Medical Center), David Neal Franz(Cincinnati Children's Hospital Medical Center), Sergiusz Jóźwiak(Children's Memorial Health Institute), Petrus de Vries, Federico Ramos(Hospital Sant Joan de Déu Barcelona), Anna Jansen(Vrije Universiteit Brussel), Mary Kay Koenig, David Mowat(UNSW Sydney), John A. Lawson(Universities UK), Kevin C. Ess(Children's Hospital Colorado), Vinodh Narayanan(Translational Genomics Research Institute), Michael Wong(Washington University in St. Louis), Stephanie Bruns(Cincinnati Children's Hospital Medical Center), Michal Tzadok(Edmond and Lily Safra Children's Hospital), Orrin Devinsky(New York University), Paolo Curatolo(University of Rome Tor Vergata), Jamie K. Capal(Cincinnati Children's Hospital Medical Center)
Cited by 81
Related Papers
Tuberous Sclerosis Complex Diagnostic Criteria Update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference
|Pediatric Neurology|2013|1.5k
Tuberous Sclerosis Complex Surveillance and Management: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference
|Pediatric Neurology|2013|863
Updated International Tuberous Sclerosis Complex Diagnostic Criteria and Surveillance and Management Recommendations
|Pediatric Neurology|2021|727
Biomarkers of Oxidative Stress Study II: Are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning?
|Free Radical Biology and Medicine|2004|697
Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man.
|Journal of Clinical Investigation|1983|671